PreOmics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3.76M
Latest Deal Amount
  • Investors
  • 10

PreOmics General Information

Description

Developer of a mass spectrometry-based proteomics technology designed to offer proteins analysis and measurement. The company's technology uses liquid chromatography coupled to a mass spectrometer to feature measurements of parameters like proteins from cells in biopsies and body fluids like blood plasma or urine, enabling researchers to discover and identify proteins as well as analyze post-translational modifications.

Contact Information

Formerly Known As
Precision Proteomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Am Klopferspitz 19
  • Martinsried
  • 82152 Planegg
  • Germany
+49 089 00000000

PreOmics Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PreOmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A) 10-Jan-2019 $3.76M 00.000 000.00 Completed Generating Revenue
6. Seed Round 06-Feb-2017 00000 Completed Generating Revenue
5. Grant 06-Jul-2016 0000 00000 Completed Generating Revenue
4. Grant 01-Mar-2016 00.000 00000 Completed Generating Revenue
3. Grant 17-Feb-2016 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator $100K $100K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view PreOmics’s complete valuation and funding history, request access »

PreOmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a mass spectrometry-based proteomics technology designed to offer proteins analysis and measurement. The co
Biotechnology
Planegg, Germany
00.000
00.00 0000-00-00
00000000000 00.000

00000000

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mol
000000000 00000 (0000000000)
Schlieren, Switzerland
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

0000000

mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
0000000000000
Hayward, CA
00 As of 0000
00000
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PreOmics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biognosys Venture Capital-Backed Schlieren, Switzerland 00 0000 00000000000 0000
0000000 Corporate Backed or Acquired Hayward, CA 00 00000 000000&0 00000
000000 Venture Capital-Backed Ithaca, NY 00000 00000
To view PreOmics’s complete competitors history, request access »

PreOmics Executive Team (4)

Name Title Board Seat Contact Info
Garwin Pichler Ph.D Co-Founder, Managing Director & Co-Chief Executive Officer
Nils Kulak Co-Founder, Managing Director & Co-Chief Executive Officer
Martin Käsemann Chief Operating Officer
Russell Golson Chief Commercial Officer
To view PreOmics’s complete executive team members history, request access »

PreOmics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andreas Schmid Lab Accelerator/Incubator Minority 000 0000 000000 0
Think.Health Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
EIT Health Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »